Repository logo
 
Publication

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

dc.contributor.authorVan Cutsem, E
dc.contributor.authorCervantes, A
dc.contributor.authorAdam, R
dc.contributor.authorSobrero, A
dc.contributor.authorVan Krieken, J H
dc.contributor.authorAderka, D
dc.contributor.authorAranda Aguilar, E
dc.contributor.authorBardelli, A
dc.contributor.authorBenson, A
dc.contributor.authorBodoky, G
dc.contributor.authorCiardiello, F
dc.contributor.authorD'Hoore, A
dc.contributor.authorDiaz-Rubio, E
dc.contributor.authorDouillard, J-Y
dc.contributor.authorDucreux, M
dc.contributor.authorFalcone, A
dc.contributor.authorGrothey, A
dc.contributor.authorGruenberger, T
dc.contributor.authorHaustermans, K
dc.contributor.authorHeinemann, V
dc.contributor.authorHoff, P
dc.contributor.authorKöhne, C-H
dc.contributor.authorLabianca, R
dc.contributor.authorLaurent-Puig, P
dc.contributor.authorMa, B
dc.contributor.authorMaughan, T
dc.contributor.authorMuro, K
dc.contributor.authorNormanno, N
dc.contributor.authorÖsterlund, P
dc.contributor.authorOyen, W J G
dc.contributor.authorPapamichael, D
dc.contributor.authorPentheroudakis, G
dc.contributor.authorPfeiffer, P
dc.contributor.authorPrice, T J
dc.contributor.authorPunt, C
dc.contributor.authorRicke, J
dc.contributor.authorRoth, A
dc.contributor.authorSalazar, R
dc.contributor.authorScheithauer, W
dc.contributor.authorSchmoll, H J
dc.contributor.authorTabernero, J
dc.contributor.authorTaïeb, J
dc.contributor.authorTejpar, S
dc.contributor.authorWasan, H
dc.contributor.authorYoshino, T
dc.contributor.authorZaanan, A
dc.contributor.authorArnold, D
dc.date.accessioned2016-07-07T20:52:13Z
dc.date.available2016-07-07T20:52:13Z
dc.date.issued2016-07-05
dc.description.abstractColorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical outcome for patients with metastatic CRC (mCRC) has improved greatly due not only to an increase in the number of patients being referred for and undergoing surgical resection of their localised metastatic disease but also to a more strategic approach to the delivery of systemic therapy and an expansion in the use of ablative techniques. This reflects the increase in the number of patients that are being managed within a multidisciplinary team environment and specialist cancer centres, and the emergence over the same time period not only of improved imaging techniques but also prognostic and predictive molecular markers. Treatment decisions for patients with mCRC must be evidence-based. Thus, these ESMO consensus guidelines have been developed based on the current available evidence to provide a series of evidence-based recommendations to assist in the treatment and management of patients with mCRC in this rapidly evolving treatment setting.pt_PT
dc.identifier.citationAnn Oncol. 2016 Jul 5. pii: mdw235. [Epub ahead of print]pt_PT
dc.identifier.doi10.1093/annonc/mdw235pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.26/14245
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.subjectNeoplasias Colorrectais/tratamentopt_PT
dc.subjectGuia de Práctica Clínicapt_PT
dc.subjectColorectal Neoplasms/therapypt_PT
dc.subjectPractice Guidelinept_PT
dc.titleESMO consensus guidelines for the management of patients with metastatic colorectal cancerpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.startPagemdw235pt_PT
oaire.citation.titleAnnals of oncology : official journal of the European Society for Medical Oncology / ESMOpt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
esmo consensus 2016 Ann Oncology.pdf
Size:
706.08 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.85 KB
Format:
Item-specific license agreed upon to submission
Description: